$12.63
▼ -0.2% Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth?
Why Is Medifast (MED) Down 7.6% Since Last Earnings Report?
Medifast Insider Bought Shares Worth $529,157, According to a Recent SEC Filing
Overview
52-week range
$9.22
$15
63% of range
Avg surprise (last 2)
+4.2%
Avg reaction (last 2)
-0.3%
50% positive
Latest IV / EM
34%
EM ±5.3% · $13 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.28 | — | — | — | — | financials |
| Mon May 4, 2026 | Mar/2026 | $-0.19 | $-0.55 | +65.5% | -72.7% | -2.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.21 | — | — | — | — | financials |
| Mon Aug 4, 2025 | Jun/2025 | $0.04 | — | — | — | — | earnings |
| Mon Apr 28, 2025 | Mar/2025 | $-0.11 | $-0.07 | -57.1% | — | +1.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.10 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.75 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.76 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $2.12 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $2.77 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $3.67 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $76M | $76M | — | $89M | $106M | $116M | — | $140M |
| Cost of revenue | $23M | $24M | — | $27M | $29M | $31M | — | $34M |
| Gross profit | $53M | $52M | — | $62M | $77M | $84M | — | $106M |
| Operating income | $-4M | $-3M | — | $-4M | $-1M | $-1M | — | $2M |
| Net income | $-3M | $-2M | — | $-2M | $2M | $-772,000 | — | $1M |
| EPS (diluted) | $-0.28 | $-0.19 | — | $-0.21 | $0.22 | $-0.07 | — | $0.10 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $72M | $72M | $89M | $100M | $102M | $92M | $91M | $115M |
| Inventory | $21M | $21M | $20M | $23M | $30M | $39M | $42M | $40M |
| Total current assets | $202M | $203M | $202M | $208M | $206M | $214M | $214M | $225M |
| Total assets | $260M | $252M | $248M | $268M | $269M | $280M | $284M | $291M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $64M | $54M | $49M | $54M | $53M | $69M | $74M | $84M |
| Total equity | $196M | $198M | $199M | $215M | $216M | $211M | $210M | $207M |